Insider Trading & Ownership - MILESON GLENNA

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for MILESON GLENNA
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-28
Purchase
2022-12-30
4:58 pm
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
50,000$2.845$142,250159,930
(Direct)
View
2022-06-23
Sale
2022-06-24
7:53 pm
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
2,614$2.69$7,032109,167
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-19
Option Award
2023-01-23
5:51 pm
N/A
2033-01-18
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
150,000$0150,000
(Direct)
View
2022-11-18
Option Award
2022-12-30
4:58 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
763$2.74159,930
(Direct)
View
2022-05-18
Option Award
2022-06-24
7:53 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
1,721$7.06109,167
(Direct)
View
2022-06-22
Option Award
2022-06-24
7:53 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
10,000$0109,167
(Direct)
View
2022-04-11
Exercise
2022-04-12
7:36 pm
N/A
2032-01-17
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
3,000$0267,060
(Direct)
View
2022-04-11
Exercise
2022-04-12
7:36 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
3,000$10.64267,060
(Direct)
View
2022-01-18
Option Award
2022-01-20
5:28 pm
N/A
2032-01-17
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
170,000$0170,000
(Direct)
View
2022-01-04
Exercise
2022-01-06
5:08 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
6,305$1.3597,060
(Direct)
View
2022-01-04
Exercise
2022-01-06
5:08 pm
N/A
2028-12-17
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
6,305$097,060
(Direct)
View
2021-11-18
Option Award
2022-01-06
5:08 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
931$12.5197,060
(Direct)
View
2021-06-10
Exercise
2021-06-10
6:48 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
6,305$1.3596,129
(Direct)
View
2021-06-10
Exercise
2021-06-10
6:48 pm
N/A
2028-12-17
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
6,305$096,129
(Direct)
View
2021-05-18
Option Award
2021-06-10
6:48 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
1,554$14.4596,129
(Direct)
View
2021-02-18
Option Award
2021-02-22
5:38 pm
N/A
2031-02-17
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
73,500$073,500
(Direct)
View

Ownership
2020-09-17
8:29 pm
N/A
N/A
Athira Pharma Inc.ATHAMILESON GLENNA
Chief Financial Officer
0$0189,780
(Direct)
View